Please Wait
Applying Filters...
USFDA APPLICATION NUMBER - 200063 / DOSAGE - TABLET, EXTENDED RELEASE;ORAL - 90MG;8MG
| Active Ingredient/Active Moiety | ||
| Ingredient Name | Basis of Strength | Strength |
|---|---|---|
| BUPROPION HYDROCHLORIDE(UNII: ZG7E5POY8O) (BUPROPION - UNII:01ZG3TPX31) | BUPROPION HYDROCHLORIDE | 90mg |
| NALTREXONE HYDROCHLORIDE(UNII: Z6375YW9SF) (NALTREXONE - UNII:5S6W795CQM) | NALTREXONE HYDROCHLORIDE | 8mg |
Inactive Ingredients
| Ingredient Name | A-S Medication Solutions | Nalpropion Pharmaceuticals LLC | Takeda Pharmaceuticals America, Inc. |
|---|---|---|---|
| ANHYDROUS LACTOSE(3SY5LH9PMK) | |||
| CELLULOSE, MICROCRYSTALLINE(OP1R32D61U) | |||
| CROSPOVIDONE (120 .MU.M)(68401960MK) | |||
| CROSPOVIDONE (15 MPA.S AT 5%)(68401960MK) | |||
| CROSPOVIDONE(68401960MK) | |||
| CYSTEINE HYDROCHLORIDE(ZT934N0X4W) | |||
| EDETATE DISODIUM(7FLD91C86K) | |||
| FD&C BLUE NO. 2(L06K8R7DQK) | |||
| HYDROXYPROPYL CELLULOSE (1200000 MW)(RFW2ET671P) | |||
| HYDROXYPROPYL CELLULOSE (1600000 WAMW)(RFW2ET671P) | |||
| HYDROXYPROPYL CELLULOSE (TYPE H)(RFW2ET671P) | |||
| HYPROMELLOSE, UNSPECIFIED(3NXW29V3WO) | |||
| HYPROMELLOSES(3NXW29V3WO) | |||
| LACTOSE MONOHYDRATE(EWQ57Q8I5X) | |||
| MAGNESIUM STEARATE(70097M6I30) | |||
| MICROCRYSTALLINE CELLULOSE(OP1R32D61U) | |||
| SILICON DIOXIDE(ETJ7Z6XBU4) |
LOOKING FOR A SUPPLIER?
Market Place
